Hypertensa™ for Vascular Function Management

Hypertensa™ is a Medical Food formulated for the management of hypertension and vascular health. Hypertensa™ helps promote nitric oxide in the peripheral blood vessels.

Distinctive Nutritional Requirements

Patients with hypertension may have nutritioinal defecencies of arginine, choline, and certain antioxidants. Patients with hypertension have reduced plasma levels of arginine. Patients with hypertension respond with oral administration of arginine. Arginine reduced diets result in a fall of circulating arginine. Patients with hypertension have activation of the arginase pathway that diverts arginine from production of nitric oxide for a given arginine blood level. Supplementation with antioxidants and arginine can restore the production of beneficial nitric oxide.

Hypertensa™ Ingredients: L-Arginine, L-Glutamine, L-Histidene, L-Cysteine, Choline, Grape Seed Extract, Ginseng, Cocoa Extract, Cinnamon, Caffeine, Dextrose. Supplied in 120 capsule bottles. 12 bottles per case. NDC # 68405-1007-02

Hypertensa™ is a Medical Food formulated to provide specific dietary management of blood pressure. Hypertensa™ is designed to produce the neurotransmitter that initiates dilation of the peripheral arteries and arterioles. Acetylcholine is the neurotransmitter that facilitates the action of nitric oxide on the hypertensive arteries and arterioles.

Hypertensa™ is designed to provide the nitric oxide presursor arginine, and the acetylcholine precursor, choline to enhance the production of nitric oxide and acetylcholine transmitters in the blood vessels.


Do not take Hypertensa™ with food.

Hypertensa™ should be taken with water on an empty stomach at least 30 minutes before or after eating.

Dosing is variable depending on the condition to be treated.

Two (2) or three capsules twice per day depending on the clinical response.

Side Effects: The side effect profile of Hypertensa™ is comparable to the rate of food intolerance in the general population. The ingredient components of Hypertensa™ are derived from nutrient based compounds found in the normal food chain. Occasional reports of slight nausea have been reported when beginning therapy. Dose titration may be needed initially. Hypertensa™ should not be taken by patients who are receiving MAO inhibitors.